ATHE
Alterity Therapeutics
$4.67
+$0.12 (+2.75%)Jul 27, 2026
Key metrics
The numbers that frame ATHE today
- Market cap
- $101.47M
- P/E (TTM)
- -9.8
- EV / FCF
- -6.9
- Gross margin
- 100%
- EV / Sales
- 10.6
- ROIC
- -336.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.66
- 52wk High
- $7.00
Growth
Revenue and earnings trend for ATHE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ATHE
Is Alterity Therapeutics a good buy?
Hold. Alterity Therapeutics has strong momentum, but poor quality makes the setup mixed. We think Alterity Therapeutics is selling at a very high price.
What is the market capitalization of ATHE?
Alterity Therapeutics's market capitalization is $101.47M.
What is the P/E ratio for ATHE stock?
Alterity Therapeutics's current P/E ratio is -9.8.
What is the 52-week high for ATHE stock?
The 52-week high for Alterity Therapeutics is $7.00. The current close of $4.67 is 33.4% below that high.
What is the 52-week low for ATHE stock?
The 52-week low for Alterity Therapeutics is $2.66. The current close of $4.67 is 75.4% above that low.
Does ATHE stock pay dividends?
Alterity Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ATHE?
Alterity Therapeutics's Debt / Equity ratio is 0.